Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Interventional
Official Title: A Phase II Trial of Pazopanib in Von Hippel-Lindau Syndrome
Brief Summary:
The goal of this clinical research study is to learn if pazopanib can help to control VHL. The safety of this drug will also be studied.
Pazopanib is designed to block the growth of blood vessels that supply nutrients needed for tumor growth. This may prevent or slow the growth of cancer cells.